These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 29614860)

  • 1. A Rational Structured Epitope Defines a Distinct Subclass of Toxic Amyloid-beta Oligomers.
    Silverman JM; Gibbs E; Peng X; Martens KM; Balducci C; Wang J; Yousefi M; Cowan CM; Lamour G; Louadi S; Ban Y; Robert J; Stukas S; Forloni G; Hsiung GR; Plotkin SS; Wellington CL; Cashman NR
    ACS Chem Neurosci; 2018 Jul; 9(7):1591-1606. PubMed ID: 29614860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-Specific Retinal and Cerebral Immunodetection of Amyloid-β Plaques and Oligomers in a Rodent Model of Alzheimer's Disease.
    Habiba U; Merlin S; Lim JKH; Wong VHY; Nguyen CTO; Morley JW; Bui BV; Tayebi M
    J Alzheimers Dis; 2020; 76(3):1135-1150. PubMed ID: 32597800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prion-Protein-interacting Amyloid-β Oligomers of High Molecular Weight Are Tightly Correlated with Memory Impairment in Multiple Alzheimer Mouse Models.
    Kostylev MA; Kaufman AC; Nygaard HB; Patel P; Haas LT; Gunther EC; Vortmeyer A; Strittmatter SM
    J Biol Chem; 2015 Jul; 290(28):17415-38. PubMed ID: 26018073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice.
    Rijal Upadhaya A; Capetillo-Zarate E; Kosterin I; Abramowski D; Kumar S; Yamaguchi H; Walter J; Fändrich M; Staufenbiel M; Thal DR
    Neurobiol Aging; 2012 Nov; 33(11):2641-60. PubMed ID: 22305478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naturally occurring autoantibodies against Aβ oligomers exhibited more beneficial effects in the treatment of mouse model of Alzheimer's disease than intravenous immunoglobulin.
    Wang T; Xie XX; Ji M; Wang SW; Zha J; Zhou WW; Yu XL; Wei C; Ma S; Xi ZY; Pang GL; Liu RT
    Neuropharmacology; 2016 Jun; 105():561-576. PubMed ID: 26907803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonhuman amyloid oligomer epitope reduces Alzheimer's-like neuropathology in 3xTg-AD transgenic mice.
    Rasool S; Martinez-Coria H; Milton S; Glabe CG
    Mol Neurobiol; 2013 Dec; 48(3):931-40. PubMed ID: 23771815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aβ oligomers trigger and accelerate Aβ seeding.
    Katzmarski N; Ziegler-Waldkirch S; Scheffler N; Witt C; Abou-Ajram C; Nuscher B; Prinz M; Haass C; Meyer-Luehmann M
    Brain Pathol; 2020 Jan; 30(1):36-45. PubMed ID: 31099449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of beta-amyloid plaques in brain of transgenic mouse model of Alzheimer's disease by EFRH-phage immunization.
    Frenkel D; Dewachter I; Van Leuven F; Solomon B
    Vaccine; 2003 Mar; 21(11-12):1060-5. PubMed ID: 12559780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic active immunization with a novel epitope vaccine improves cognitive ability by decreasing amyloid plaques and neuroinflammation in APP/PS1 transgenic mice.
    Ding L; Meng Y; Zhang HY; Yin WC; Yan Y; Cao YP
    Neurosci Res; 2017 Jun; 119():7-14. PubMed ID: 28111220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorine-19 Magnetic Resonance Imaging for Detection of Amyloid β Oligomers Using a Keto Form of Curcumin Derivative in a Mouse Model of Alzheimer's Disease.
    Yanagisawa D; Ibrahim NF; Taguchi H; Morikawa S; Tomiyama T; Tooyama I
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33806326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The conformational epitope for a new Aβ42 protofibril-selective antibody partially overlaps with the peptide N-terminal region.
    Colvin BA; Rogers VA; Kulas JA; Ridgway EA; Amtashar FS; Combs CK; Nichols MR
    J Neurochem; 2017 Dec; 143(6):736-749. PubMed ID: 28881033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary DHA supplementation in an APP/PS1 transgenic rat model of AD reduces behavioral and Aβ pathology and modulates Aβ oligomerization.
    Teng E; Taylor K; Bilousova T; Weiland D; Pham T; Zuo X; Yang F; Chen PP; Glabe CG; Takacs A; Hoffman DR; Frautschy SA; Cole GM
    Neurobiol Dis; 2015 Oct; 82():552-560. PubMed ID: 26369878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxycycline counteracts neuroinflammation restoring memory in Alzheimer's disease mouse models.
    Balducci C; Santamaria G; La Vitola P; Brandi E; Grandi F; Viscomi AR; Beeg M; Gobbi M; Salmona M; Ottonello S; Forloni G
    Neurobiol Aging; 2018 Oct; 70():128-139. PubMed ID: 30007162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naturally occurring autoantibodies against beta-amyloid: investigating their role in transgenic animal and in vitro models of Alzheimer's disease.
    Dodel R; Balakrishnan K; Keyvani K; Deuster O; Neff F; Andrei-Selmer LC; Röskam S; Stüer C; Al-Abed Y; Noelker C; Balzer-Geldsetzer M; Oertel W; Du Y; Bacher M
    J Neurosci; 2011 Apr; 31(15):5847-54. PubMed ID: 21490226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous Monitoring of Amyloid-β (Aβ) Oligomers and Fibrils for Effectively Evaluating the Dynamic Process of Aβ Aggregation.
    Yu Y; Yin T; Peng Q; Kong L; Li C; Tang D; Yin X
    ACS Sens; 2019 Feb; 4(2):471-478. PubMed ID: 30693761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synaptotoxicity in Alzheimer's Disease Involved a Dysregulation of Actin Cytoskeleton Dynamics through Cofilin 1 Phosphorylation.
    Rush T; Martinez-Hernandez J; Dollmeyer M; Frandemiche ML; Borel E; Boisseau S; Jacquier-Sarlin M; Buisson A
    J Neurosci; 2018 Nov; 38(48):10349-10361. PubMed ID: 30341179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformation-sensitive antibodies against alzheimer amyloid-beta by immunization with a thioredoxin-constrained B-cell epitope peptide.
    Moretto N; Bolchi A; Rivetti C; Imbimbo BP; Villetti G; Pietrini V; Polonelli L; Del Signore S; Smith KM; Ferrante RJ; Ottonello S
    J Biol Chem; 2007 Apr; 282(15):11436-45. PubMed ID: 17267402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strikingly reduced amyloid burden and improved behavioral performance in Alzheimer's disease mice immunized with recombinant chimeric vaccines by hexavalent foldable Aβ₁₋₁₅ fused to toxin-derived carrier proteins.
    Yu YZ; Wang WB; Chen A; Chang Q; Liu S; Zhao M; Wang S; Qiu WY; Pang XB; Xu Q; Sun ZW
    J Alzheimers Dis; 2014; 41(1):243-60. PubMed ID: 24625800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quaternary Structure Defines a Large Class of Amyloid-β Oligomers Neutralized by Sequestration.
    Liu P; Reed MN; Kotilinek LA; Grant MK; Forster CL; Qiang W; Shapiro SL; Reichl JH; Chiang AC; Jankowsky JL; Wilmot CM; Cleary JP; Zahs KR; Ashe KH
    Cell Rep; 2015 Jun; 11(11):1760-71. PubMed ID: 26051935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active immunization with the peptide epitope vaccine Aβ3-10-KLH induces a Th2-polarized anti-Aβ antibody response and decreases amyloid plaques in APP/PS1 transgenic mice.
    Ding L; Meng Y; Zhang HY; Yin WC; Yan Y; Cao YP
    Neurosci Lett; 2016 Nov; 634():1-6. PubMed ID: 27693663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.